This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
In total, 1,301 eligible women were invited between October 1996 and February 1998 to participate in the study. Of these, 407 (31%) refused consent and did not participate in the study. The authors reported that there was no significant difference in age between those granting consent (mean age 40 years, standard deviation, SD=7.0) and those who refused (mean age 41 years, SD=7.7), (p=0.56). The reasons for refusal were not reported. Post-randomisation no patients were excluded for any reason. The women were randomly assigned to one of the three groups. There were 298 in control group, 296 in the information group, and 300 in the information plus interview group. The mean age of the participants was 40 years (SD=7.0) in the control group, 40 years (SD=7.2) in the information group, and 41 years (SD=6.9) in the information plus interview group.
Study design
The basis of the analysis was a multi-centre, randomised controlled trial that was conducted in 6 hospitals. The women (patients) were randomly allocated using a form of random permuted block size, randomly set to 3, 6 or 9 to avoid selection bias. The allocation sequence was generated by computer and stratified by consultant and the age that the woman left full-time education. Using a central telephone randomisation system helped to ensure randomisation. Neither the patients nor the investigators were blinded.
The duration of follow-up was 2 years and was conducted using questionnaires sent at 6, 12 and 24 months postconsultation. Women who did not respond to the 24-month questionnaire after receiving 2 reminder letters were asked to take part in a short telephone interview covering key items from the follow-up questionnaire. The response rate to the 2 years' follow-up was 70%. The mean duration of follow-up was 26 months for each group. Although the rates of loss to follow-up varied between the groups, the differences were not statistically significant, (p=0.69). However, the authors did find statistically significant differences in baseline characteristics between non-responders and responders. These were reported in full. The authors stated that a statistical analysis would ensure that these differences would not affect comparisons between the trial groups. No reasons for the loss to follow-up were reported.
Analysis of effectiveness
The basis for the analysis was treatment completers only. The primary outcome of the study was health status measured by the 36-item short form health survey (SF-36). The secondary outcomes included treatments received during followup, severity of menorrhagia, and patient satisfaction. Severity of menorrhagia was assessed using a menorrhagia outcome scale (see Other Publications of Related Interest). The educational background of the sample was stated to be close to population averages. The three groups were generally well matched, although there were small between-group differences in the duration of menorrhagia and in experience of hormone and non-hormone treatments. It was not apparent whether any adjustment for these confounding variables was undertaken.
Effectiveness results
The role of physical dimension of the SF36 showed a significant difference between the interview, non-interview and control groups, (p=0.04). The other seven dimensions of the SF-36 and menorrhagia severity were stated to be non significant. The authors only provided a graphical depiction of the results obtained.
Among women who underwent hysterectomy, the interview group showed significant reductions in hysterectomy rate when compared with the control group (26% relative reduction; p=0.04) and with the information group (32% relative reduction), (adjusted odds ratio, OR=0.52; 95% confidence interval, CI: 0.33 -0.82; p=0.008).
There were no statistically significant differences between the information and control groups, (p=0.53). No other treatments showed a significant between-group difference. However, the authors reported that the number of women who received endometrial destruction or other treatment was too small to rule out the effect.
The intervention groups may have been more likely to undergo drug therapy, but the differences were not statistically significant (information versus control, p=0.17; interview versus control, p=0.11).
As far as satisfaction was concerned, the interview group rated both the opportunities they had been given to take part in treatment decision-making (adjusted OR 1.49, 95% CI: 1.11 -2.01; p=0.008) and the overall results of their treatments (adjusted OR 1.44, 95% CI: 1.03 -2.01; p=0.03) significantly higher than did the control group.
The differences between the information group and the controls were smaller and not significant. The adjusted OR was 1.24 (95% CI: 0.91 -1.69) for opportunities to take part in decision-making and 1.16 (95% CI: 0.85 -1.60) for results of treatment. The differences between the intervention groups were not statistically significant.
Clinical conclusions
The authors concluded that neither of the intervention had a major impact on health status. In terms of the effects on treatment received, women who received the interview (plus information) were considerably less likely to undergo hysterectomy than those who received information alone.
Measure of benefits used in the economic analysis
No summary health benefit was used in the economic analysis. The study was, in effect, a cost-consequences analysis.
Direct costs
The direct costs to the health service were included in the analysis, more specifically, the costs of tests and treatment.
The tests considered were dilation and curettage, endometrial biopsy, laparoscopy, hysteroscopy, ultrasound scan, blood test, colposcopy and examination under anaesthetic. The treatments covered were hormonal drug, non-hormonal drug, hysterectomy, endometrial destruction, polyp removal, fibroid removal, and levonorgestrel-releasing intrauterine contraceptive device. These costs included any inpatient stay, and outpatient or physician visit when required. In addition, the costs of inpatient days in gynaecology, surgery and medical clinics were included. These costs excluded any cost of stay associated with particular procedures, as well as the cost of outpatient or family physician visits for menorrhagia or other conditions. Discounting was not relevant, as the costs were incurred during 2 years, and was not performed. The unit costs and resource use were reported separately. The unit costs were derived from published sources.
A total cost per patient was reported for the information intervention and for the information plus interview. This included the cost of the booklet and videotape, plus 20 minutes of an experienced nurse's time for the interview.
Although it was assumed that these costs were incurred for more than 2 years, they were not discounted.
Statistical analysis of costs
The total costs were treated deterministically, while differences in the costs between the two treatment groups and the control group were treated stochastically (mean difference and 95% CI reported). The CIs for the differential costs were obtained using bias-corrected and accelerated nonparametric bootstrapping. The problem of resource data being missing was addressed using multivariate multiple imputation methods, under the assumption that these data were missing at random. reference costs (see Other Publications of Related Interest). Therefore, although the authors used, for example, average inpatient day costs, it can be assumed that all the relevant costs (i.e. overheads) were included. The cost analysis did not include the cost of the intervention itself, although it was reported. Therefore, it is difficult to assess, whether the implementation of the interventions resulted in real cost-savings overall. The costs were taken from published sources and adjusted to the year 2000, and were updated for inflation where necessary. Details of the method of adjustment were not reported. With the exception of the costs of the intervention, where the total fixed costs (e.g. development and production of the booklet and videotape) were reported in an aggregated fashion, the costs were reported separately from the quantities. This will aid generalisability. Discounting was not relevant to the patient's treatment costs since the timeframe was 2 years.
Other issues
The authors compared their results with those of other studies, finding consistency for most of the results. Two inconsistencies were reported. First, in one systematic review, although a reduction in the rate of radical surgery due to intervention was also established, the effect size reported proved to be similar, irrespective of the content of the interventions. Second, the effect of the interview on satisfaction was not established in other studies that measured satisfaction. However, the authors stated that these other studies had limited power to detect between-group differences in satisfaction. The issue of generalisability to other settings was only raised as far as the observed differences in baseline characteristics between responders and non-responders were concerned.
